Skip to content

Effects of Cichorium Intybus L. Leaf Extract on improvement of the clinical status of patients with periodontal

The effects of non-surgical periodontal therapy with Cichorium Intybus L. Leaf Extract on antioxidant status, inflammation and blood lipid status of patients with periodontal disease

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2015112825274N1
Enrollment
40
Registered
2016-01-14
Start date
2014-04-21
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

periodental. Periodontal disease, unspecified

Interventions

Intervention 1: Intervention group1: Consumption of two one-gram capsules daily containing total of 2 grams of Cichorium Intybus L. Leaf extract (By using fresh leaf of Cichorium Intybus L from Kan
Intervention group1: Consumption of two one-gram capsules daily containing total of 2 grams of Cichorium Intybus L. Leaf extract (By using fresh leaf of Cichorium Intybus L from Kandovan city, loca
Control group: Consumption of two one-gram capsules daily containing 2 grams of wheat flour (capsules prepared by the Center for Pharmaceutical Research, Tabriz University of Medical Sciences), in the

Sponsors

Vice chancellor for research of Arvand International Division of Ahvaz Jundishapur University of Med
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: age over 30 years; having periodontal disease (PPD more than 4 millimeter) in at least one site in the three quarters of the mouth); BMI more than 18.5 Kilogram/ square meter. Exclusion criteria: lack of cooperation; pregnancy and lactation; smoking; use of dietary supplements and antioxidant; Consumption of anti cariogenic gum; Consumption of drugs that suppress the immune system; changes in diet pattern and hyperlipidemia.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Interleukin-6. Timepoint: Before and two months after intervention. Method of measurement: ELISA.;Hs-CRP. Timepoint: Before and two months after intervention. Method of measurement: ELISA.;Malon de aldehid (MDA). Timepoint: Before and two months after intervention. Method of measurement: chemical method (Kit).;Blood uric acid. Timepoint: Before and two months after intervention. Method of measurement: chemical method.;Triglycerides. Timepoint: Before and two months after intervention. Method of measurement: Enzymatic.;Cholesterol. Timepoint: Before and two months after intervention. Method of measurement: Enzymatic.;HDL-cholesterol. Timepoint: Before and two months after intervention. Method of measurement: Enzymatic.;Total antioxidant capacity of blood. Timepoint: Before and two months after intervention. Method of measurement: Enzymatic.

Secondary

MeasureTime frame
Weight. Timepoint: Before and two months after intervention. Method of measurement: scale.;Height. Timepoint: Before and two months after intervention. Method of measurement: Stadiometer.;Energy intake. Timepoint: Before and two months after intervention. Method of measurement: recall.;Carbohydrate intake. Timepoint: Before and two months after intervention. Method of measurement: recall.;Protein intake. Timepoint: Before and two months after intervention. Method of measurement: recall.;Fat intake. Timepoint: Before and two months after intervention. Method of measurement: recall.;Saturated Fat. Timepoint: Before and two months after intervention. Method of measurement: recall.;Vitamin A. Timepoint: Before and two months after intervention. Method of measurement: recall.;Vitamin C. Timepoint: Before and two months after intervention. Method of measurement: recall.;Vitamin E. Timepoint: Before and two months after intervention. Method of measurement: recall.;Betacaroten. Timepoint: Before and two months after intervention. Method of measurement: recall.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAhmad Zare Javid

Ahvaz Jundishapur University of Medical Sciences

zarejavid-a@ajums.ac.ir+98 61 3373 8319

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026